Gennisium Pharma is a young French pharmaceutical company, which intends to develop, register and commercialize medicines dedicated to premature newborns and niche markets. Gennisium is looking for providing health care practitioners and neonatal intensive care units with novel and suitable formulations of medicines needed to prevent or treat neonatal diseases and conditions. Our company’s project aims to provide patients with medicines based on affordable prices and with global reach, regardless where the infants are born, whether in privileged or underprivileged countries. Feel free to contact us on info@gennisium.com